How to obtain clinical trial information opportunities for new drugs and new devices? Ruijin Hospital opens two outpatient clinics to light up "lights" for patients

Release time:May 20, 2024 14:14 PM

“For desperate patients with advanced cancer, trying new drugs as early as possible is undoubtedly a light in the darkness.”

Shen Baiyong, deputy director of Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, said so. In recent years, the public's understanding of clinical trials of new drugs is changing: many patients will take the initiative to ask doctors whether there are new clinical trials to participate in, and more and more patients understand that clinical research is based on full patient knowledge and ethics. Medical exploration under protection and active participation in clinical research will become the fastest and most direct beneficiaries of new drugs and treatments, and this is the meaning of medical clinical trials.

Today is the 20th International Clinical Trials Day. This year’s theme is “Guard Health, Light Up Hope.” In order to further promote the development of clinical research, Ruijin Hospital today established a clinical research multidisciplinary consultation clinic and a Ruijin-Hainan licensed new drug and new device consultation clinic. The establishment of these two clinics will provide patients with more professional and comprehensive clinical trial consulting services, helping patients better understand and participate in clinical trials.

As early as 1997, Ruijin Hospital obtained the qualification of a national clinical drug trial base and subsequently expanded into the field of medical devices. Today, the institution has 35 drug clinical trial majors and 43 medical device clinical trial majors. Nearly a hundred professors lead research and carry out the use of new drugs and new devices. The test areas cover digestion, cardiovascular, endocrinology, blood, burns, orthopedics, Medical imaging, respiratory, infection, nephrology, neurology, urology, skin, oncology, obstetrics and gynecology, anesthesia, traditional Chinese medicine orthopedics, general surgery, pediatrics, critical care, thoracic surgery, ophthalmology and other majors.

"In addition to treating patients, Ruijin Hospital also has an important mission, which is clinical research." Shen Baiyong said that Ruijin Hospital undertakes about 200 to 300 registered clinical research projects and nearly 500 clinical research projects independently initiated by researchers every year. Research, the scale ranks first in the national medical system.

Today, this platform is even closer to patients. "Through the clinical trial clinic, Ruijin can help patients 'find drugs' around the world." Shen Baiyong explained that for new drugs that have not yet been launched in the country, patients can consult a doctor through this clinic. After a comprehensive evaluation, Ruijin Hospital will coordinate Introduce the required drugs to the Hainan branch and provide treatment to patients through clinical trial procedures.

“Generally speaking, it often takes 3 to 5 years for a drug to be launched from clinical trials to approval. However, with the help of the Ruijin Hainan Hospital platform, the waiting period is greatly shortened, and patients can use the most cutting-edge medicines without having to travel overseas. Jin Jiabin, deputy director of Hainan Branch, said that as an exclusive domestic pilot, Ruijin Hainan Hospital in Boao Lecheng actively promotes the application of new drugs and new devices, so that new drugs and new devices that have not yet been approved in China can pass clinical trials. Research methods are used by patients as early as possible.

On June 22, 2022, 10-year-old girl Zheng Ni successfully received vorsolide injection treatment at Ruijin Hainan Hospital. Vorsolitide is currently the only drug approved in the world for children with achondroplasia. It is also the first new drug project in the country to be launched by Ruijin Hainan Hospital.

Since then, many patients with Alzheimer's disease, ALS, hypertension, allergic rhinitis, etc. have also used new drugs in Hainan's "zero time difference". In May last year, the pancreatic surgery team successfully performed a single-hole da Vinci robotic surgery at Ruijin Hainan Hospital. 74-year-old Grandma Wang became the first clinical case in the world. At the same time, relevant data were also provided to the U.S. Food and Drug Administration to apply for a pancreatic surgery license. certificate.

Since the "14th Five-Year Plan", the drug and medical device clinical trial institution of Ruijin Hospital has undertaken 498 clinical evaluations of new drugs and 93 clinical trials of medical devices, including 143 leading projects and 172 international multi-center projects, successfully assisting the country's first cell therapy Products Akilenza Injection, "Zhangjiang R&D and Made in Shanghai" independently developed oral Class 1 innovative drug deuterated remidevir hydrobromide tablets, my country's first Class 1.1 natural drug new drug Xiangleitang Foot Ointment, and the first domestically produced proton therapy device The system and the country’s first innovative pharmaceutical device using deep learning technology software were approved for marketing.

At the same time, Ruijin Hospital is also actively exploring the field of clinical research initiated by researchers. In 2017, the Ruijin Hospital Clinical Research Center was established as a public service platform for clinical medical research in the hospital to provide researchers with one-stop technical support, covering research plan design. , data management, statistical analysis, training, etc., and also undertakes the project review and management tasks of IIT research. The platform provides support for Academician Ning Guang’s BPROAD research, Professor Zhao Qiang’s expanded research published in the Journal of the American Medical Association, and major clinical research projects in the second round of Senkon’s three-year action plan; participating in the design has great scientific significance and application prospects. Clinical research plans, such as Professor Shen Bai’s research on treating pancreatic cancer with mRNA vaccine. During the COVID-19 epidemic, the center invested heavily in innovative IIT research such as hydroxychloroquine and VV116, and relevant results were published in the British Medical Journal and the New England Journal of Medicine.

comment
This is the first foreign patient in China to benefit from related therapies, and a Singaporean mother of three has completed CAR-T therapy in Shanghai
This is the first foreign patient in China to benefit from related therapies, and a Singaporean mother of three has completed CAR-T therapy in Shanghai

Exploring new platforms and therapies for social medical services in Shanghai, providing diversified services to patients. Since CAR-T therapy was approved for sale in China, Shanghai Jiahui International Cancer Center has collaborated with domestic and foreign partners to build an international CAR-T diagnosis and treatment platform. Recently, the first foreign patient in China to receive CAR-T treatment with Achillense injection was successfully discharged after 3 weeks of infusion of CAR-T cells. On the day of discharge, Jiahui medical staff and her relatives and friends gathered in the ward for a special "discharge commemoration ceremony". Lyn, who is 40 years old, comes from Singapore and is a mother of three. She has settled in Shanghai for 15 years. Last year in the middle of the year, she suddenly felt pain in her shoulders, neck, and upper limbs, and couldn't sleep well all night. Her symptoms continued to worsen. Emergency examination at Jiahui Hospital revealed a huge mass with a diameter of 15 centimeters in the mediastinum! Block compression causes limb pain,

Entering households to deliver medicine to the people, Fudan Shangyi's "Bo Yi Tuan" has been walking deep in the mountains for 29 consecutive years to provide services | medical | Bo Yi Tuan
Entering households to deliver medicine to the people, Fudan Shangyi's "Bo Yi Tuan" has been walking deep in the mountains for 29 consecutive years to provide services | medical | Bo Yi Tuan

This summer, the doctoral medical service team of Fudan University Shanghai Medical College, known as the "white angels walking deep in the mountains," set off as usual to travel to remote areas of our country and take on the mission of being a doctor in volunteer service. It is reported that since its establishment in 1994, the "Bo Yi Tuan" has been committed to leveraging the professional knowledge of medical doctoral students and providing medical assistance with exquisite skills every year, so that people can enjoy high-quality and efficient medical and health services at their doorstep. Data shows that over the past 29 years, the "Bo Yi Tuan" has served more than 10000 days and nights, with over a thousand people participating in the work of the Bo Yi Tuan. It has carried out large-scale free medical services for 50000 people, covering over 100000 kilometers. The service coverage has expanded to 38 hospitals in 26 counties and 16 provinces, cities, and autonomous regions across the country. The first stop of the "Bo Yi Tuan" to carry out medical and health volunteer work in Gong'an County, Hubei Province

Gradually covering all hospitalized newborns, World Breastfeeding Week | Fudan Pediatric Breast Bank will expand and double the capacity of premature infants | breastfeeding | human milk
Gradually covering all hospitalized newborns, World Breastfeeding Week | Fudan Pediatric Breast Bank will expand and double the capacity of premature infants | breastfeeding | human milk

From the 1st to the 7th, it will be the 32nd World Breastfeeding Week. According to reports from the Pediatric Hospital affiliated with Fudan University, since the establishment of Shanghai's first NICU breast milk bank in 2017, through continuous efforts, the breastfeeding rate for extremely/ultra-low birth weight premature infants has increased from 25% to 100%. Within this year, the human milk storage facility will be relocated to a new building, while further expanding and doubling its capacity. Breastfeeding will gradually cover all hospitalized newborns. Professor Cao Yun, Director of the Department of Neonatology at a pediatric hospital, stated that for many newborns with premature birth, low birth weight, infection, and intestinal diseases, breast milk can improve the digestive and absorption functions and immune abilities of the child's gastrointestinal tract, exert anti-inflammatory and antibacterial effects, promote the establishment of enteral nutrition in critically ill newborns after gastrointestinal surgery, reduce the incidence of serious diseases in premature infants, promote the growth and development of premature infants, postpartum recovery of mothers, and physical health

National renowned traditional Chinese medicine practitioners have initiated a prospective randomized study on drugs, with approximately 15 million people in China suffering from this gynecological disease, ovarian syndrome, and traditional Chinese medicine
National renowned traditional Chinese medicine practitioners have initiated a prospective randomized study on drugs, with approximately 15 million people in China suffering from this gynecological disease, ovarian syndrome, and traditional Chinese medicine

Polycystic ovary syndrome (PCOS) is a disease that affects the health of women throughout their lives. The incidence rate of PCOS accounts for 6-10% of women of childbearing age and 80-85% of women who do not ovulate. There are about 15 million patients in China. The combination of traditional Chinese and Western medicine has a unique therapeutic effect on polycystic ovary syndrome. To verify clinical efficacy, the prospective randomized controlled multicenter clinical research project on the treatment of polycystic ovary syndrome with kidney yang deficiency and phlegm obstruction type and kidney yin deficiency and phlegm stasis combination type by Shenluo Tiaojing Pill and Shenluo Yuchun Pill has been officially launched today. The reporter learned that Shenluo Tiaojing Pill and Shenluo Yuchun Pill are the core drugs for the diagnosis and treatment of polycystic ovary syndrome based on the classification of traditional Chinese and Western medicine gynecological experts and nationally renowned traditional Chinese medicine professor Yu Jin. They were approved for clinical application as hospital preparations in 2021. Professor Yu Jin's introduction: Polycystic ovary syndrome not only leads to infertility in patients

Fudan Pediatrics completed 2 pediatric coronary artery bypass surgeries within 5 hours, building a "bridge of life" on the beating heart. Team | Discipline | Pediatrics
Fudan Pediatrics completed 2 pediatric coronary artery bypass surgeries within 5 hours, building a "bridge of life" on the beating heart. Team | Discipline | Pediatrics

Due to the appearance of a huge coronary artery aneurysm and occlusion after suffering from Kawasaki disease, two children went to the National Children's Medical Center Fudan University Affiliated Pediatric Hospital for treatment. A multidisciplinary team developed an individualized coronary artery bypass surgery plan for them. In the end, the two children underwent surgery on the same day and were reborn. They recovered and were discharged smoothly recently. 9-year-old Heihei and 5-year-old Ana sought medical attention due to chest pain, palpitations, post activity fatigue, and decreased activity. They were diagnosed with Kawasaki disease, giant coronary artery aneurysm, coronary artery occlusion, and myocardial ischemia. They sought medical attention from multiple hospitals across the country but were unsuccessful. Parents came to Fudan University Affiliated Pediatric Hospital with their last hope for treatment. Professor Liu Fang, the director of the cardiology department, received the patient and carefully reviewed the relevant examination materials before telling the parents, "Please rest assured that we can treat it!"